Bharat Biotech asked to submit complete phase 2 data of its COVID-19 vaccine before phase 3 trial
Posted by
www.biotecnika.org
According to officials, the Hyderabad-based vaccine maker applied to
the Drugs Controller General of India (DCGI) on October 2, seeking its
permission to conduct phase-3 randomised double-blind
placebo-controlled multicentre trial of its COVID-19 vaccine
candidate.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-asked-to-submit-complete-phase-2-data-of-its-covid-19-vaccine-before-phase-3-trial/articleshow/78589479.cms
Subscribe to:
Post Comments (Atom)
Post a Comment